By David S. Muntz, CHCIO, CDH-E, FHIMSS, Principal and Co-Founder of StarBridge Advisors
David Muntz, CHCIO, CDH-E, FHIMSS, is Principal and Co-Founder of StarBridge Advisors and a 40+ year healthcare IT leader. He has served as CIO at major health systems, including Texas Health Resources and Baylor Health Care System. He was the first Principal Deputy National Coordinator and CIO at ONC (HHS), and CIO of GetWellNetwork. A Fellow of CHIME and HIMSS, he teaches in Baylor University’s EMBA program.
Though there has been a modest proliferation of C-suite titles recently, healthcare organizations do not create new C-suite roles lightly. They do so when complexity outpaces existing leadership structures; hence, the recent emergence of the Chief AI Officer (CAIO) role. Artificial intelligence, particularly generative AI, has moved rapidly from experimentation into operations, clinical, and financial domains. With that shift comes new opportunities, new risks, and new forms of value that require coordinated leadership.
The CAIO role represents healthcare’s effort to bring coherence and accountability to a rapidly expanding AI footprint. This evolution follows a familiar pattern. As the CIO role grew in scope, responsibilities were distributed to CISOs, CTOs, and CDOs. Similarly, clinical practice evolved through specialties and subspecialties to manage increasing complexity.
For the CAIO, use cases now span ambient clinical documentation, decision support, imaging augmentation, contact center automation, revenue cycle intelligence, and the reduction of administrative burden. AI capabilities are increasingly embedded directly into enterprise platforms including EHRs. As AI becomes part of core infrastructure, it demands executive-level oversight not only to ensure financial return, but to balance value, risk, flexibility, and long-term organizational impact.
Popular and unpopular trends: what’s working and what isn’t
AI-mature organizations are moving away from “pilot proliferation” toward portfolio management. They are prioritizing fewer use cases, aligning them with enterprise strategy, identifying accountable owners, and measuring outcomes. AI governance councils are becoming common, or their responsibilities are being embedded within existing governance structures. AI needs clear intake, review, approval, and monitoring processes. The CAIO’s value lies in converting ambition into repeatable operating models that consider the Value of Investment (VOI) framework which requires a holistic approach to valuation. VOI includes but is not limited to measurable tangible and intangible operational benefits, workforce impact (particularly usability and satisfaction), and risk along with traditional financial measurements such as ROI.
Successful deployment also requires practical and pragmatic sequencing as determined via AI governance. Many organizations begin with operational AI use cases, e.g., documentation burden reduction, scheduling optimization, call center automation, coding and authorization support. Building confidence in these areas makes it easier to expand AI into higher-risk clinical decision support. Early wins build confidence, generate near-term productivity and financial benefits, and confirm the value of governance needed for more complex applications.
Unpopular trends are equally instructive. Shadow AI persists in many organizations, often outpacing data readiness, workflow redesign, safety controls, and ethical considerations. Ineffective CAIOs lack budget authority or the ability to stop unsafe or duplicative initiatives. Equally damaging is overly complex governance slowing progress without providing safe paths for experimentation. The results are predictable: unmanaged risk, erosion of trust, and value leakage that rarely appear on a balance sheet.
How organizations shape the Chief AI Officer and how CAIOs reshape organizations
The CAIO role is inherently contextual. Academic medical centers often emphasize research translation, partnerships, and clinical validation. Community systems under margin pressure prioritize access, productivity, and workforce relief. Highly regulated environments demand heavier emphasis on governance, auditability, and vendor scrutiny.
Effective CAIOs can reshape organizations in consistent ways. They can establish and evolve an AI-enabled production system with standardized intake, prioritization, risk-based governance, and a delivery model that clearly distinguishes between leveraging existing investments, building internally, buying, or partnering. Continuous monitoring and adjustment are essential. Governance discipline transforms AI from a series of experiments into an enterprise capability creating optionality and resilience rather than isolated point solutions.
I contacted Ivan Bartolome, President and CEO of HealthSearch Partners who shared his thoughts. Bartolome said, “I don’t think we should view the “Chief AI Officer” role as just another trendy and expensive C-suite role. Artificial Intelligence is already here, and we are surrounded by it. It’s only going to accelerate. In a few years we will look at organizations without AI like we look at hospitals with quad patient rooms and deem them antiquated. Hospitals and health care organizations need to properly harness the virtues of AI. It will speed up processes and make care delivery more accurate. All of this benefits the patient and family while protecting operational financial viability and mission. The right CAIO leader in your organization can help you make sure it is deployed correctly and in a way that embraces and strengthens your culture.”
The CAIO profile
The strongest CAIOs are not defined by how many models they can train, but by their ability to lead enterprise change and manage tradeoffs under uncertainty.
Must-have capabilities include:
- Executive operating experience leading cross-functional transformation,
- Deep understanding of healthcare workflows and patient safety culture,
- Practical AI literacy, including limitations, bias, drift, and evaluation,
- Strong vendor and contracting judgment, and
- An instinct for governance that enables speed while protecting enterprise value.
Nice-to-have characteristics include:
- Background in informatics, data science, or statistics,
- Proven experience scaling AI beyond pilots,
- Board- and staff-level communication skills, and
- Credibility with clinical leadership through strong CMO, CNO, and CMIO partnerships.
Screening and measuring CAIO success
Interviewing a CAIO should resemble a simulation rather than a resume review. Effective screening should focus on strategy and portfolio management, governance and safety frameworks, workflow integration, value realization, executive influence, and clear communication across stakeholders. Candidates must be able to distinguish use cases, platform capability, and governance and articulate the tradeoffs among them.
Performance should be assessed on outcomes rather than outputs, including operational and clinical value, workforce impact, safety and compliance, adoption, governance maturity, and the organization’s ability to reduce unmanaged risk such as shadow AI.
Executive team membership and reporting lines
In most healthcare organizations, the CAIO should be part of the executive team when AI is enterprise-wide and risk-bearing. Executive presence enables prioritization, informed tradeoff decisions, and enforcement of standards. Depending upon the type of organization, reporting lines should align with who owns outcomes and can adjudicate competing priorities, perhaps the CEO, COO, CMO, or CIO.
Final thought
When properly empowered, the CAIO enables AI to advance what I call the Sextuple Aim: improving patient experience and outcomes, strengthening population health, reducing cost and administrative burden, supporting clinician well-being, advancing equity, and sustaining organizational performance. With commitment from the executive team, the CAIO can ensure AI investments serve the mission and the margin.
